Metso to publish its Financial Statements Review for 2015

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Metso to publish its Financial Statements Review for 2015 on Thursday, February 4, 2016

HELSINKI, Finland, Jan. 21, 2016 (GLOBE NEWSWIRE) -- Metso Corporation's Financial Statements Review 2015 will be published on Thursday, February 4, 2016 at about 9:00 a.m. EET (2:00 EST, 7:00 UTC, 8:00 CET). The Financial Statements Review will also be available at www.metso.com/latestreports .

Metso will arrange a results audiocast on the day at 13:00 EET which is viewable at www.metso.com/latestreports . A simultaneous conference call will be arranged which allows participants to ask questions. A recording of the event will be available at the same webpage at the earliest after the event has finished and a transcript will be available for downloading on Tuesday, February 9, 2016 at the latest.

Conference call details Conference call participants are requested to dial in five minutes before the scheduled time on: United States: +1 646 254 3362 other countries: +44 (0)20 3427 1911

The confirmation code for joining the conference call is 3735943

Metso will not arrange a separate event at its headquarters for investors, analysts or media. Requests for interviews and additional information, please contact the persons listed below.

Metso Corporation

Juha Rouhiainen Vice President, Investor Relations Tel. +358 20 484 3253

Metso is the world's leading industrial company in the mining and aggregates industries and in the flow control business. Our knowledge, people and solutions help drive sustainable improvements in performance and profitability in our customers ' businesses.

Metso has an uncompromising attitude towards safety. Our products range from mining and construction equipment and systems to industrial valves and controls. Our solutions are delivered and supported by decades of process knowledge and a broad scope of services backed by a global footprint of over 90 service centers, thousands of service employees, and an extensive logistics network. Metso is listed on the NASDAQ OMX Helsinki, Finland. In 2014, Metso's net sales totaled EUR 3.7 billion. Metso employs approximately 13,000 industry experts in more than 50 countries. Expect results.

www.metso.com , www.twitter.com/metsogroup

For further information, please contact:

Investors and analysts: Seija Fabritius, Investor relations coordinator, Metso Corporation, tel: +358 20 484 3117

Representatives of the media: Emilia Peltola, Communications Manager, Global Communications, Metso Corporation, tel: +358 20 484 3161

HUG#1980442

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 11

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Sprott Physical Gold Trust Celebrates Impressive Growth Milestone

Updated Category News Views 180

Sprott Physical Gold Trust Achieves $10 Billion NAV Milestone TORONTO — Sprott Inc. is thrilled to announce that the Sprott Physical Gold Trust (PHYS) has hit a significant milestone with its net asset value reaching US$10 billion. This achievement highlights the increasing confidence investors have in gold as a fundamental asset during uncertain times. John Ciampaglia,...

Continue Reading
ORIC Pharmaceuticals Reveals Promising Combination Data for Cancer

Updated Category News Views 158

Encouraging Developments in Oncology from ORIC Pharmaceuticals ORIC Pharmaceuticals is making significant strides in the field of oncology with promising early phase 1b combination data for ORIC-944, which is currently being evaluated alongside other treatments in clinical trials. Recent Progress in Clinical Trials The latest data reveals encouraging results from ongoing...

Continue Reading
Alpari Unveils Insights on Market Shifts Post Trump Policies

Updated Category News Views 244

Understanding Market Dynamics After Recent Policy Changes Alpari has recently published an insightful report analyzing the shifts in market dynamics in response to the early policy decisions of the current administration. The financial world is already observing assets reacting to recent executive orders and tariff announcements, with analysts keeping a vigilant eye on...

Continue Reading
PG&E Foundation's Significant Support for Local Food Initiatives

Updated Category News Views 217

PG&E Foundation Takes Action Against Food Insecurity The PG&E Corporation Foundation, also known as The PG&E Foundation, is stepping up to help alleviate hunger by donating a remarkable $1.12 million. This significant contribution is set to bolster more than 50 food banks, tribal food banks, and senior meal programs that provide essential support to the growing number of...

Continue Reading
Newtopia's Third Quarter Results Showcase Resilient Growth

Updated Category News Views 144

Newtopia's Significant Financial Progress in Q3 2024 Newtopia Inc. continues to solidify its place in the global healthcare landscape with a strong report for the third quarter of 2024. The company is strategically positioned to capitalize on significant market opportunities that arise from the focus on preventive health measures. This comes in conjunction with the new...

Continue Reading